PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.27%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-4.56%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-25.71%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-29.63%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-26.28%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-26.27%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-26.27%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.00%
Share reduction more than 1.5x 3391.T's 0.01%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
59.93%
10Y revenue/share CAGR under 50% of 3391.T's 187.92%. Michael Burry would suspect a lasting competitive disadvantage.
66.65%
5Y revenue/share CAGR at 50-75% of 3391.T's 89.46%. Martin Whitman would worry about a lagging mid-term growth trajectory.
33.46%
3Y revenue/share CAGR at 50-75% of 3391.T's 45.17%. Martin Whitman would question if the firm lags behind competitor innovations.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
41.85%
Below 50% of 3391.T's 200.88%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
40.83%
5Y net income/share CAGR at 50-75% of 3391.T's 69.13%. Martin Whitman might see a shortfall in operational efficiency or brand power.
-8.53%
Negative 3Y CAGR while 3391.T is 0.04%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
126.08%
5Y equity/share CAGR above 1.5x 3391.T's 81.85%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
59.09%
3Y equity/share CAGR above 1.5x 3391.T's 37.35%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
-9.09%
Negative 5Y dividend/share CAGR while 3391.T stands at 109.93%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
42.86%
3Y dividend/share CAGR 1.25-1.5x 3391.T's 37.04%. Bruce Berkowitz checks if the company's short-term profits or payout policy justify these higher hikes.
67.36%
AR growth well above 3391.T's 9.05%. Michael Burry fears inflated revenue or higher default risk in the near future.
2.88%
Inventory growth well above 3391.T's 4.02%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
1.82%
Asset growth well under 50% of 3391.T's 4.13%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
2.86%
50-75% of 3391.T's 5.04%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-4.54%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
2.21%
SG&A growth well above 3391.T's 3.08%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.